Ramoplanin, a new lipoglycodepsipeptide antibiotic, was uniformly active against 65 strains of enterococci, including strains higly resistant to vancomycin, penicillin G, and gentamicin. MBCs were usually within a fourfold dilution of the MICs. In time-kill studies, ramoplanin alone demonstrated dose-dependent bactericidal activity against enterococcal strains that resisted killing by vancomycin or penicillin in combination with gentamicin.
Generally, the spectrum of activity of ramoplanin is similar to that of vancomycin, but it has been reported to be four to eight times more active than vancomycin (6) . Moreover, ramoplanin has greater bactericidal activity than the other glycopeptide antibiotics against strains of S. aureus and streptococci (11, 13) . Ramoplanin also shows good activity against strains of Enterococcus, including those with moderate levels of resistance to ampicillin and vancomycin (22) . The present study was undertaken to evaluate the activity of ramoplanin against a large number of strains of Enterococcus, including those that are highly resistant to vancomycin, penicillin G, and gentamicin. In addition, the bactericidal activity of the antibiotic was investigated in time-kill studies.
All enterococcal strains used in this study were unique clinical isolates recovered from patients located at our own and several regional medical centers between 1988 and 1991. Species identification was performed by using the automated MicroScan Walkaway System (Baxter Healthcare Corp., West Sacramento, Calif.) (20) . Aliquots of each strain were frozen in cation-supplemented Mueller-Hinton broth (MHiB) until required for study. All strains were clinically and epidemiologically unrelated. Vancomycin-resistant strains were confirmed as unique isolates by restriction endonuclease analysis of plasmid content.
The MICs of ramoplanin, vancomycin, teicoplanin, daptomycin, and penicillin (Sigma Chemical Co., St. Louis, * Corresponding author.
Mo.) were determined by the conventional agar dilution method (17) . Antibiotics were prepared fresh on the day of the experiment and were diluted according to the manufacturers' recommendations. The following antibiotic powders were generously provided by the indicated manufacturers: ramoplanin and teicoplanin, Marion Merrell Dow Pharmaceuticals, Cincinnati, Ohio, and vancomycin and daptomycin, Eli Lilly & Co., Indianapolis, Ind.
A broth dilution method was also used to determine the MICs for selected enterococcal strains (n = 14) (17) . All isolates were tested by using cation-supplemented MHB (20 to 25 mg of Ca2+ per liter) and a final inoculum of 5 x 105 to 1.0 x 106 CFU/ml. In experiments with daptomycin and ramoplanin, MICs were also determined in unsupplemented MHB to which calcium chloride was added to achieve final concentrations of 0, 25, 50, 100, and 200 mg of Ca2" per liter.
The MIC was read as the lowest concentration of each antimicrobial agent that prevented turbidity after 18 h of incubation at 37°C. MBCs, which were defined as the lowest concentration of drug that reduced the original inoculum by 299.9% within 18 h, were determined as described by Pearson et al. (15) . To test for the presence of high-level aminoglycoside resistance, 105 CFU of each strain per ml was incubated in the presence of 500 ,ug of gentamicin per ml in MHB. Resistance was defined as the presence of visible turbidity after 18 h of incubation.
Time-kill studies were performed on six enterococcal isolates that were resistant to vancomycin, penicillin G, high levels of gentamicin, or a combination of these. Survival of these strains was studied in flasks of MHB alone and in flasks containing MHB with vancomycin (50 ,ug/ml), penicillin G (50 pg/ml), and ramoplanin (at various concentrations), with and without gentamicin (3 ,ug/ml). A bacterial inoculum in the logarithmic phase of growth was added to each flask to achieve a final concentration of 5 x 105 CFU/ml. Time-kill studies with ramoplanin were also performed by using a final bacterial concentration of 107 CFU/ml. The flasks were then incubated in a shaking water bath at 37°C. Samples were removed at times of 0, 3, 6, and 24 h for enumeration by serial dilution and plating. Drug carryover effects were eliminated by dilution below the MIC for the organism. The lowest accurately countable number in the time-kill studies was 30 CFU/ml (1.5 in log1o units). All in vitro microbiologic studies were performed at least twice. The susceptibilities of 65 strains of enterococci (E. faeof gentamicin (3 ,uglml) with ramoplanin at a concentration cium, n = 32; E. faecalis, n = 30, and E. durans, n = 3) to of 0.5 x the MIC (Fig. 1) . Ramoplanin was equally bacterivarious antimicrobial agents are reported in Table 1 . Eight of cidal in time-kill studies when an initial high inoculum of 107 these isolates were highly vancomycin resistant (MIC, 2200 CFU/ml was used. ,ug/ml) and 19 were highly penicillin G resistant (MIC, 2200 Clinical observations and evidence from experimental p,g/ml). Ramoplanin was uniformly active against all isolates, models suggest that antibiotic treatment of serious enteroregardless of their susceptibilities to other antimicrobial coccal infections such as endocarditis requires bactericidal agents. By broth dilution methods, ramoplanin MICs were activity (8, 10, 12) . This has usually been achieved by a essentially identical to those determined by agar dilution.
combination of vancomycin or penicillin with gentamicin. Bactericidal activity was observed against all 14 tested When resistance to one or all of these agents occurs, no strains. MBCs were within a twofold dilution of the MIC for alternative treatment has been established as efficacious (5) . six strains, within a fourfold dilution for six strains, and
In this study, ramoplanin demonstrated excellent activity within an eightfold dilution for two strains. The activity of against all enterococci, including those resistant to other ramoplanin was neither increased nor decreased by variation antimicrobial agents. Furthermore, ramoplanin had rapid, of the calcium ion concentration of the medium, whereas the dose-dependent bactericidal activity that did not require the activity of daptomycin was markedly enhanced by an inaddition of an aminoglycoside. There was no cross-resiscrease in the calcium ion concentration.
tance between ramoplanin and glycopeptide (vancomycin, In time-kill studies with selected resistant isolates, vancoteicoplanin) or lipopeptide (daptomycin) antibiotics. This is mycin and penicillin, alone or in combination with gentamiconsistent with observed differences in their structures and cin, failed to reduce colony counts at 24 h for five of the six mechanisms of action (4) . Ramoplanin inhibits cell wall strains (Table 2) . However, ramoplanin demonstrated rapid, synthesis by acting at the level of lipid-intermediate formadose-dependent bactericidal activity against all isolates. Altion or utilization, whereas vancomycin and daptomycin though killing occurred faster with the addition of gentamiinterfere with peptidoglycan synthesis by preventing transcin, synergy at 24 h was observed only for the combination glycosylation (19) . In preliminary studies, ramoplanin has been poorly tolerated following intravenous or intramuscular injection. However, it has been considered promising as a topical agent because of its spectrum of activity, lack of systemic absorption, and good local tolerability (2) . Since nosocomial transmission of antibiotic-resistant strains of enterococci has been associated with fecal carriage, ramoplanin may have a role in eradicating colonization from the gastrointestinal tract (16, 23 
